The bill establishes a new section in Florida law, titled "Patient right to try individualized investigational treatment," which allows eligible patients with life-threatening or severely debilitating illnesses to request and receive personalized investigational treatments under specific conditions. It defines key terms such as "eligible facility," "eligible patient," and "individualized investigational treatment," and outlines the requirements for patients to qualify for such treatments, including the need for written informed consent and documentation from their physician. The bill also permits eligible facilities and manufacturers to provide these treatments, while clarifying that health plans and governmental agencies are not required to cover the costs associated with them.

Additionally, the bill includes provisions to protect patients and healthcare providers involved in the process. It states that heirs of deceased patients are not liable for any outstanding debts related to the investigational treatment, and it prohibits licensing boards from taking disciplinary action against physicians solely for recommending these treatments. State officials are also barred from obstructing patient access to individualized investigational treatments. Importantly, the bill specifies that it does not create a private cause of action against manufacturers or caregivers for harm resulting from the use of these treatments, provided they comply with the law. The act is set to take effect on July 1, 2025.